Bausch + Lomb Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $13.84 High: $14.14
on July 9, 2025

52 Week Range

Low: $10.45 High: $21.69
on April 30, 2025
on October 14, 2024

All-Time High: $21.95 on June 26, 2023

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $4.1B
EPS i N/A
P/E Ratio (TTM) i -13.33
Forward P/E i 9.86
P/B Ratio i 0.65
PEG Ratio i 9.86
Div. Yield i N/A
ROE i -5.36%
Beta i N/A
Debt to Equity i 75.07

Financial Highlights

Profitability

Gross Margin i 57.61%
Operating Margin i N/A
Profit Margin i N/A

Returns and Earnings

Return on Assets (TTM) i N/A
Return on Equity (TTM) i -5.36%
EBITDA i N/A
Net Income (TTM) i N/A

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i
Quarterly Revenue Growth i
Quarterly Earnings Growth i

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Bausch + Lomb BLCO 4.15B Mid-cap4.09%16.86%27.27%-22.57%-22.22%-13.36%-11.42%129.78%
Intuitive Surgical ISRG 184.62B Large-cap-1.99%0.22%15.22%-3.07%0.62%20.39%153.51%146.51%
Becton, Dickinson BDX 48.64B Large-cap-1.71%1.23%-13.05%-25.51%-22.90%-24.51%-27.71%-33.60%
Avantor AVTR 9.25B Mid-cap-1.22%2.23%-3.71%-37.87%-35.14%-35.05%-52.98%-27.95%
Repligen RGEN 6.93B Mid-cap1.68%-2.37%18.06%-16.90%-10.13%-1.18%-25.39%-7.36%
Stevanato STVN 6.40B Mid-cap-1.09%5.05%32.09%2.46%9.61%12.16%63.75%23.79%

Ownership & Short Interest

Insider Ownership i 88.17%
Institutional Ownership i 11.01%
Shares Short i 3M
Short Ratio i 2.39
Short % of Shares Outstanding i 6.03%
Average 10-Day Volume i 674K
Average 90-Day Volume i 679K

Bausch + Lomb Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bausch + Lomb would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BLCO's 52-week high and low?

In the last 52 weeks, Bausch + Lomb reached a high of $21.69 (on October 14, 2024) and a low of $10.45 (on April 30, 2025).

What is the market cap and P/E ratio for BLCO?

Curious about Bausch + Lomb's size and valuation? Its market capitalization stands at 4.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is -13.33, and the forward P/E (looking ahead) is 9.86.

Does BLCO pay dividends? If so, what's the yield?

As for dividends, Bausch + Lomb isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Bausch + Lomb's main competitors or similar companies to consider before investing?

When looking at Bausch + Lomb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Intuitive Surgical
ISRG
184.62BHealthcareMedical Instruments & Supplies20.39%153.51%
Becton, Dickinson
BDX
48.64BHealthcareMedical Instruments & Supplies-24.51%-27.71%
Avantor
AVTR
9.25BHealthcareMedical Instruments & Supplies-35.05%-52.98%
Repligen
RGEN
6.93BHealthcareMedical Instruments & Supplies-1.18%-25.39%
Stevanato
STVN
6.40BHealthcareMedical Instruments & Supplies12.16%63.75%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bausch + Lomb Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Bausch + Lomb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -5.36%, the Debt to Equity ratio from the most recent quarter is 75.07, and its Gross Profit Margin stands at 57.61%.

What is the recent revenue and earnings growth for BLCO?

Looking at Bausch + Lomb's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.50%, and quarterly earnings saw a YoY growth of 3.46%.

How much of BLCO stock is held by insiders and institutions?

Wondering who owns Bausch + Lomb stock? Company insiders (like executives and directors) hold about 88.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 11.01%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.